Pieris Pharmaceuticals Inc (PIRS) Insider Trading
- $591,000.00
- $25,854,365.56
- Aug. 12, 2024
- Orbimed Advisors Llc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 12, 2024 | Major Shareholder | 3,000 | $15.88 | Buy | $47,640.00 | |
| Aug. 9, 2024 | Major Shareholder | 3,000 | $14.89 | Buy | $44,670.00 | |
| May 25, 2023 | Director | 10,000 | $0.85 | Buy | $8,500.00 | |
| May 13, 2022 | Insider | 6,000 | $1.71 | Buy | $10,260.00 | |
| Aug. 30, 2021 | Insider | 38,400 | $5.11 | Sell | $196,224.00 | |
| July 21, 2020 | Major Shareholder | 1,900,000 | $2.95 | Sell | $5,605,000.00 | |
| Sept. 6, 2019 | Major Shareholder | 50,000 | $4.50 | Sell | $225,000.00 | |
| Sept. 14, 2018 | Director | 5,000 | $5.11 | Buy | $25,550.00 | |
| May 15, 2018 | Director | 10,000 | $5.75 | Buy | $57,500.00 | |
| April 30, 2018 | Insider | 1,000,000 | $6.35 | Sell | $6,350,000.00 | |
| Feb. 13, 2018 | Major Shareholder | 7,897 | $8.98 | Sell | $70,915.06 | |
| Jan. 3, 2018 | Major Shareholder | 1,709,620 | $7.35 | Sell | $12,565,707.00 | |
| Dec. 18, 2017 | Major Shareholder | 147,635 | $5.70 | Sell | $841,519.50 | |
| Aug. 17, 2017 | Director | 10,000 | $4.82 | Buy | $48,200.00 | |
| Aug. 17, 2017 | Insider | 65,000 | $4.82 | Buy | $313,300.00 | |
| June 14, 2016 | SVP | 10,000 | $1.70 | Buy | $17,000.00 | |
| June 13, 2016 | CFO | 5,000 | $1.66 | Buy | $8,300.00 | |
| June 13, 2016 | CEO | 6,000 | $1.68 | Buy | $10,080.00 |
Insiders are both buying and selling Pieris Pharmaceuticals Inc stock.
The insider traders at Pieris Pharmaceuticals Inc are: Orbimed Advisors Llc, Adar1 Capital Management, Llc, Christopher P Kiritsy, James A Geraghty, Stephen S Yoder, Darlene M Deptula-Hicks, Tim Demuth, Louis Matis, Allan Reine, Shane Olwill, Aquilo Capital Management, Llc, and Bvf Partners L P/Il
The most active insider trader at Pieris Pharmaceuticals Inc is Orbimed Advisors Llc with 4 trades.
Orbimed Advisors Llc has sold the most Pieris Pharmaceuticals Inc stock with a total value of $26,178,141.56.
Allan Reine has bought the most Pieris Pharmaceuticals Inc stock with a total value of $626,600.00.
The most recent insider trade for Pieris Pharmaceuticals Inc was on Aug. 12, 2024.
The single biggest insider buy for Pieris Pharmaceuticals Inc was from Allan Reine with a total value of $313,300.00 on Aug. 17, 2017.
The single biggest insider sell for Pieris Pharmaceuticals Inc was from Orbimed Advisors Llc with a total value of $12,565,707.00 on Jan. 3, 2018.